Response to Letter to the Editor from Hao and Xue: "Checkpoint Inhibitor-associated Autoimmune Diabetes Mellitus Is Characterized by C-Peptide Loss and Pancreatic Atrophy"

Linda Wu; Matteo Salvatore Carlino; David Alexander Brown; Georgina Venetia Long; Roderick Clifton-Bligh; Rhiannon Mellor; Krystal Moore; Sarah Christina Sasson; Alexander Maxwell Menzies; Venessa Tsang; Jenny Elizabeth Gunton

doi:10.1210/clinem/dgae555

Response to Letter to the Editor from Hao and Xue: "Checkpoint Inhibitor-associated Autoimmune Diabetes Mellitus Is Characterized by C-Peptide Loss and Pancreatic Atrophy"

J Clin Endocrinol Metab. 2025 Jan 21;110(2):e552-e553. doi: 10.1210/clinem/dgae555.

Authors

Linda Wu^{1

2

3

4}, Matteo Salvatore Carlino^{2

4

5}, David Alexander Brown^{1

2

4

6}, Georgina Venetia Long^{4

5

7}, Roderick Clifton-Bligh^{3

4}, Rhiannon Mellor², Krystal Moore², Sarah Christina Sasson^{2

4}, Alexander Maxwell Menzies^{4

5

7}, Venessa Tsang^{3

4}, Jenny Elizabeth Gunton^{1

2

4}

Affiliations

¹ Centre for Diabetes and Endocrinology, Westmead Institute for Medical Research, Westmead, NSW 2145, Australia.
² Westmead Hospital, Westmead, NSW 2145, Australia.
³ Department of Endocrinology, Royal North Shore Hospital, St Leonards, NSW 2065, Australia.
⁴ Faculty of Medicine and Health, University of Sydney, Camperdown, NSW 2050, Australia.
⁵ Melanoma Institute Australia, The Poche Centre, Wollstonecraft, NSW 2065, Australia.
⁶ Institute of Clinical Pathology and Medical Research, NSW Health Pathology, Westmead, NSW 2145, Australia.
⁷ Department of Medical Oncology, Royal North Shore Hospital, St Leonards, NSW 2065, Australia.

PMID: 39136234
DOI: 10.1210/clinem/dgae555

No abstract available

Publication types

Editorial
Comment